Pfizer saw the highest growth of 112% in patent filings in January and 103% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 112% and grants by 75%. GlobalData’s DataBook provides a comprehensive analysis of Pfizer‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Pfizer has been focused on protecting inventions in United States(US) with 95 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 26% filings and 20% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Japan(JP) patent Office are among the top ten patent offices where Pfizer is filings its patents. Among the top granted patent authorities, Pfizer has 20% of its grants in United States(US), 13% in Australia(AU) and 5% in Japan(JP).

F. Hoffmann-La Roche and Johnson & Johnson could be the strongest competitors for Pfizer

Pfizer stands in second position with respect to its patent publications among its competitors.

Patents related to rare diseases and nanomedicine lead Pfizer's portfolio

Pfizer has the highest number of patents in rare diseases followed by, nanomedicine and climate change. For rare diseases, nearly 54% of patents were filed and 55% of patents were granted in Q1 2024.

Breast cancer related patents lead Pfizer portfolio followed by lymphoma, and multiple myeloma (kahler disease)

Pfizer has highest number of patents in breast cancer followed by lymphoma, multiple myeloma (kahler disease), alzheimer's disease, and leukemia. For breast cancer, nearly 2% of patents were filed and 1% of patents were granted in Q1 2024.

For comprehensive analysis of Pfizer's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.